Pulse Biosciences Inc Avanti P/E
Cos'è Avanti P/E di Pulse Biosciences Inc?
Avanti P/E di Pulse Biosciences Inc è -25.38
Qual è la definizione di Avanti P/E?
Il rapporto prezzo / utili a termine è il rapporto tra il prezzo delle azioni di una società e l'utile stimato per azione della società per i prossimi dodici mesi.
The forward price to earnings ratio is similar to trailing price to earnings ratio but instead of net income uses estimated net earnings over next 12 months. Estimates are typically derived as the mean of those published by a select group of analysts with selection criteria varying. The forward price-to-earnings ratio is a powerful, but limited tool. It allows a quick snapshot of the company’s finances without getting down in the details of an accounting report.
Avanti P/E di aziende nel Health Care settore su NASDAQ rispetto a Pulse Biosciences Inc
Cosa fa Pulse Biosciences Inc?
pulse biosciences, inc. is a clinical stage electroceutical, an electrical energy based therapeutic, company pursuing commercial applications of its proprietary nano-pulse stimulation (nps) technology. nps is a non-thermal, drug-free energy-based technology that can stimulate unique behaviors in cells by applying ultra-short nanosecond (billionths of a second) electrical pulses that affect the cell membrane and intracellular structures. these cell effects influence cell regulation functions and can lead to unique immune system responses. pulse biosciences is investigating a variety of applications for its nps technology that exploits its unique biologic effect, including immuno-oncology and dermatology. pulse biosciences, inc. (plse, nasdaq) corporate headquarters is located in hayward, ca. ~ our mission ~ to build a viable company that designs, produces, and commercializes nano-pulse technology to improve and extend the lives of patients to solve the needs of patients, physicians, and
Aziende con avanti p/e simili a Pulse Biosciences Inc
- Silex Systems ha Avanti P/E di -26.00
- White Gold ha Avanti P/E di -26.00
- NexGen ha Avanti P/E di -25.80
- Moderna Inc ha Avanti P/E di -25.68
- BELLUS Health ha Avanti P/E di -25.66
- Enviri Corp ha Avanti P/E di -25.49
- Pulse Biosciences Inc ha Avanti P/E di -25.38
- Silence Therapeutics Plc ha Avanti P/E di -25.28
- Calyxt Inc ha Avanti P/E di -25.20
- nLIGHT Inc ha Avanti P/E di -24.15
- Soleno Therapeutics Inc ha Avanti P/E di -23.96
- Performant Corp ha Avanti P/E di -23.95
- Rhythm Pharmaceuticals ha Avanti P/E di -23.85